Literature DB >> 11301217

Chronic inflammatory demyelinating polyneuropathy in childhood.

A M Connolly1.   

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is relatively rare. However, it has been recognized for many years. In patients presenting with this disease, subacute onset of weakness usually develops over at least 2 months and often progresses to a loss of ambulation. Some children's initial presentations may mimic Guillain-Barré syndrome. Dysasthesias are common. Males are affected more than females, and antecedent illnesses or vaccinations occur in approximately half of patients. Physical examination reveals diffuse, proximal greater than distal weakness, with an absence or depression of muscle stretch reflexes. Electrophysiology confirms demyelination, and spinal fluid examination demonstrates albuminocytologic dissociation. The clinical presentation, diagnosis, and prognosis of childhood CIDP are reviewed. Treatment and immunologic features are also discussed in this article.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301217     DOI: 10.1016/s0887-8994(00)00237-x

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

Review 1.  IVIG therapy in neurological disorders of childhood.

Authors:  Juan J Archelos; Franz Fazekas
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

2.  A case of cauda equina syndrome in early-onset chronic inflammatory demyelinating polyneuropathy clinically similar to charcot-marie-tooth disease type 1.

Authors:  Seung Eun Lee; Seung Won Park; Sam Yeol Ha; Taek Kyun Nam
Journal:  J Korean Neurosurg Soc       Date:  2014-06-30

3.  Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update.

Authors:  Alberto Spalice; Pasquale Parisi; Laura Papetti; Francesco Nicita; Fabiana Ursitti; Francesca Del Balzo; Enrico Properzi; Alberto Verrotti; Martino Ruggieri; Paola Iannetti
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

4.  Inflammatory demyelinating neuropathies.

Authors:  Glenn Lopate; Alan Pestronk
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.972

5.  Genetic spectrum of hereditary neuropathies with onset in the first year of life.

Authors:  Jonathan Baets; Tine Deconinck; Els De Vriendt; Magdalena Zimoń; Laetitia Yperzeele; Kim Van Hoorenbeeck; Kristien Peeters; Ronen Spiegel; Yesim Parman; Berten Ceulemans; Patrick Van Bogaert; Adolf Pou-Serradell; Günther Bernert; Argirios Dinopoulos; Michaela Auer-Grumbach; Satu-Leena Sallinen; Gian Maria Fabrizi; Fernand Pauly; Peter Van den Bergh; Birdal Bilir; Esra Battaloglu; Ricardo E Madrid; Dagmara Kabzińska; Andrzej Kochanski; Haluk Topaloglu; Geoffrey Miller; Albena Jordanova; Vincent Timmerman; Peter De Jonghe
Journal:  Brain       Date:  2011-08-11       Impact factor: 13.501

6.  Surgical treatment and intraoperative spinal cord monitoring in scoliosis associated with chronic inflammatory demyelinating polyneuropathy: a case report.

Authors:  Daisuke Kudo; Naohisa Miyakoshi; Michio Hongo; Yuji Kasukawa; Yoshinori Ishikawa; Akiko Misawa; Yoichi Shimada
Journal:  Ups J Med Sci       Date:  2013-01-11       Impact factor: 2.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.